A detailed history of Bancreek Capital Management, LP transactions in Danaher Corp stock. As of the latest transaction made, Bancreek Capital Management, LP holds 61,013 shares of DHR stock, worth $14.3 Million. This represents 11.38% of its overall portfolio holdings.

Number of Shares
61,013
Previous 56,267 8.43%
Holding current value
$14.3 Million
Previous $14.1 Million 20.65%
% of portfolio
11.38%
Previous 11.64%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$239.25 - $280.76 $1.14 Million - $1.33 Million
4,746 Added 8.43%
61,013 $17 Million
Q2 2024

Aug 09, 2024

BUY
$235.51 - $267.98 $88,551 - $100,760
376 Added 0.67%
56,267 $14.1 Million
Q1 2024

May 03, 2024

SELL
$224.58 - $256.19 $1.1 Million - $1.25 Million
-4,892 Reduced 8.05%
55,891 $14 Million
Q4 2023

Feb 07, 2024

SELL
$185.1 - $233.13 $19,805 - $24,944
-107 Reduced 0.18%
60,783 $14.1 Million
Q3 2023

Nov 01, 2023

BUY
$233.08 - $265.59 $2.52 Million - $2.87 Million
10,810 Added 21.59%
60,890 $15.1 Million
Q2 2023

Aug 10, 2023

BUY
$224.99 - $256.14 $2.79 Million - $3.18 Million
12,416 Added 32.97%
50,080 $12 Million
Q1 2023

May 05, 2023

BUY
$239.75 - $277.0 $3.73 Million - $4.31 Million
15,552 Added 70.33%
37,664 $9.49 Million
Q4 2022

Feb 08, 2023

BUY
$241.42 - $282.29 $194,101 - $226,961
804 Added 3.77%
22,112 $5.87 Million
Q3 2022

Nov 09, 2022

BUY
$247.06 - $1507.4 $167,259 - $1.02 Million
677 Added 3.28%
21,308 $5.5 Million
Q2 2022

Aug 09, 2022

BUY
$237.11 - $299.66 $76,112 - $96,190
321 Added 1.58%
20,631 $5.23 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $1.6 Million - $1.97 Million
6,224 Added 44.19%
20,310 $5.96 Million
Q4 2021

Feb 09, 2022

BUY
$292.08 - $329.01 $4.11 Million - $4.63 Million
14,086 New
14,086 $4.63 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Bancreek Capital Management, LP Portfolio

Follow Bancreek Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bancreek Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bancreek Capital Management, LP with notifications on news.